Browsing Covid-19 Documents -HIQA [edeposit] by Title
Now showing items 54-73 of 133
-
Evidence summary for universal face mask use by healthcare workers in the context of COVID-19
(Health Information and Quality AuthorityIE, 2020-08-13) -
Evidence summary for use of rapid antigen testing for screening or surveillance of asymptomatic individuals to limit transmission of SARS-CoV-2. Submitted to NPHET: 24 August 2021
(Health Information and Quality AuthorityIE, 2021-09-20) -
Evidence summary of placental transfer of antibodies
(Health Information and Quality AuthorityIE, 2020-05-13) -
Evidence summary of potential for children to contribute to transmission of SARS-CoV-2
(Health Information and Quality AuthorityIE, 2020-06-23) -
Evidence summary of potential for children to contribute to transmission of SARS-CoV-2
(Health Information and Quality AuthorityIE, 2020-08-21) -
Evidence summary of potential for children to contribute to transmission of SARS-CoV-2
(Health Information and Quality AuthorityIE, 2020-05-13) -
Evidence summary of public health measures to limit the transmission of SARS-CoV-2 at mass gatherings. Submitted to NPHET: 25 May 2021
(Health Information and Quality AuthorityIE, 2021-06-17) -
Evidence summary of reinfection and the duration of antibody responses following SARS-CoV-2 infection
(Health Information and Quality AuthorityIE, 2020-11-11) -
Evidence summary of the duration of immunity and reinfection following SARS-CoV-2 infection; protocol
(Health Information and Quality AuthorityIE, 2020-11-11) -
Evidence summary of the immune response following infection with SARS-CoV-2 or other human coronaviruses
(Health Information and Quality AuthorityIE, 2020-06-09) -
Evidence summary of the immune response following infection with SARS-CoV-2 or other human coronaviruses
(Health Information and Quality AuthorityIE, 2020-05-13) -
Evidence summary of the immune response following infection with SARS-CoV-2 or other human coronaviruses
(Health Information and Quality AuthorityIE, 2020-08-06) -
Evidence summary of the infectiousness of individuals reinfected with SARS-CoV-2 or other human coronaviruses
(Health Information and Quality AuthorityIE, 2020-05-13) -
Evidence summary protocol: Duration of protective immunity following COVID-19 vaccination (efficacy and effectiveness)
(Health Information and Quality AuthorityIE, 2021-09-03) -
Evidence summary protocol: Duration of protective immunity following SARS-CoV-2 infection
(Health Information and Quality AuthorityIE, 2020-05-20) -
Evidence summary: COVID-19 - Interventions and health-related factors that prevent infection or minimise progression to severe disease. Submitted to NPHET: 12 May 2021
(Health Information and Quality AuthorityIE, 2021-08-13) -
Evidence synthesis for groups in vaccine allocation group nine - those aged 18-64 years living or working in crowded conditions. Submitted: 23 March 2021
(Health Information and Quality AuthorityIE, 2021-03-31) -
Face mask use by healthy people in the community to reduce SARS-CoV-2 transmission - protocol for rapid evidence update
(Health Information and Quality AuthorityIE, 2020-12-17) -
Factors influencing, and measures to improve, vaccination uptake: rapid evidence summary
(Health Information and Quality AuthorityIE, 2020-12-16) -
Factors influencing, and measures to improve, vaccination uptake: rapid evidence summary protocol
(Health Information and Quality AuthorityIE, 2020-12-16)